Investigating Doxorubicin’s mechanism of action in cervical cancer: a convergence of transcriptomic and metabolomic perspectives
Introduction: Cervical cancer remains a significant global health burden, and Doxorubicin is a crucial therapeutic agent against this disease. However, the precise molecular mechanisms responsible for its therapeutic effects are not fully understood.Methods: In this study, we employed a multi-omics...
Main Authors: | Zhuo Huang, Huining Jing, Juanjuan Lv, Yan Chen, YuanQiong Huang, Shuwen Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2023.1234263/full |
Similar Items
-
Changes in Uterine Metabolome Associated with Metritis Development and Cure in Lactating Holstein Cows
by: Eduardo B. de Oliveira, et al.
Published: (2023-11-01) -
Integration of transcriptomics, metabolomics, and lipidomics reveals the mechanisms of doxorubicin-induced inflammatory responses and myocardial dysfunction in mice
by: Xin Tan, et al.
Published: (2023-06-01) -
Biomarkers of PEGylated Liposomal Doxorubicin-Induced Hypersensitivity Reaction in Breast Cancer Patients Based on Metabolomics
by: Wei Zhuang, et al.
Published: (2022-04-01) -
Longitudinal Metabolomics Reveals Ornithine Cycle Dysregulation Correlates With Inflammation and Coagulation in COVID-19 Severe Patients
by: Tao Li, et al.
Published: (2021-12-01) -
Oral Intake of L-Ornithine-L-Aspartate Is Associated with Distinct Microbiome and Metabolome Changes in Cirrhosis
by: Angela Horvath, et al.
Published: (2022-02-01)